Consensus of follow-up intervals for patients with idiopathic intracranial hypertension (IIH) based on their papilloedema grade and their visual field status
| Papilloedema grade | Normal | Visual field status | ||
| Affected but improving | Affected but stable | Affected but worsening | ||
| Atrophic | 4–6 months | Within 4 weeks | ||
| Mild | 6 months | 3–6 months | 3–4 months | Within 4 weeks |
| Moderate | 3–4 months | 1–3 months | 1–3 months | Within 2 weeks |
| Severe | 1–3 months | Within 4 weeks | With 1 week | |
Note: Once papillodema has resolved, visual monitoring within the hospital services may no longer be required. However, caution in those patients who were asymptomatic at presentation, as they will likely be asymptomatic if a recurrence occurs and longer term follow-up, may need to be considered.